The Fight To Claim A Cure – Above the Law
Above the Law |
The Fight To Claim A Cure
Above the Law The sick patient is infused with genetically modified T–cells, natural cancer killers, prompting an immune response that sometimes results in the body killing off the cancer on its own. While CAR-T therapy doesn’t work yet for all patients and all … |
JD Supra (press release) |
Broad Institute backs central Crispr patent licensing platform
Chemistry World (subscription) The Broad Institute in Cambridge, US, and its partners Harvard University, the Massachusetts Institute of Technology and The Rockefeller University have submitted 22 patents in response to a call to create a joint licensing pool for Crispr genome … A CRISPR patent pool – one step closer to reality?JD Supra (press release) |
Drug Target Review |
CNIC scientists find the key to improved cancer immunotherapy
Drug Target Review The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell – one circulating in the blood and the other resident in tissues – that can be reactivated with current immunotherapy … |
Drug Target Review |
CNIC scientists find the key to improved cancer immunotherapy
Drug Target Review The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell – one circulating in the blood and the other resident in tissues – that can be reactivated with current immunotherapy … |
|
Stem Cell Therapy for Heart Failure Gets a Gold-Standard Trial
Scientific American One company, Melbourne, Australia–based Mesoblast, is already in late-stage clinical trials, treating hundreds of chronic heart failure patients with stem cell precursors drawn from healthy donors’ hip bones. A randomized trial that includes a placebo … |
|
Oppenheimer Begins Coverage on Editas Medicine, Inc. (EDIT) With An Initial Rating Of “Perform”
First News 24 CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
|
Oppenheimer Begins Coverage on Editas Medicine, Inc. (EDIT) With An Initial Rating Of “Perform”
First News 24 CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevotella and Francisella 1), bound to a guide RNA molecule designed to recognize a particular … |
Technology Networks |
Synthetic Material to Support Stem Cells Developed
Technology Networks This week, a UW–Madison team reports in Nature Biomedical Engineering that they have jumped a major hurdle on the path toward wider use of stem cells. Using an automated screening test that they devised, William Murphy, a professor of biomedical … |